IGHV Gene Mutation Analysis near me in Asansol

The immunoglobulin heavy chain variable region gene (IgHV) mutation status has been an established prognostic factor in patients with CLL. B-cells harboring IGHV help fight infections by making antibodies. In a disease called Chronic Lymphocytic Leukemia (CLL), some B-cells become unhealthy and grow out of control. Doctors look at the changes in the IGHV to understand how the CLL might behave.

This is a PCR-based investigational test to determine the mutational status of IGHV by employing multiple consensus DNA primers that target conserved genetic regions within the immunoglobulin heavy chain (IGH) gene.

The IGHV mutation status acts as a crucial prognostic indicator, distinguishing between mutated (M-CLL) and unmutated (UM-CLL) subtypes, guiding treatment approaches, and predicting response to therapy, ultimately shaping personalized management strategies for patients.